skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Inhibition of rat brain monoamine oxidase by repeated administration of pirlindol

Journal Article · · Bull. Exp. Biol. Med. (Engl. Transl.); (United States)
DOI:https://doi.org/10.1007/BF00837284· OSTI ID:6906897

Since pirlindol, like other antidepressants, is used for a long time and since its therapeutic effect usually appears 5-7 days or more after the beginning of treatment, the authors investigate its action on activity of MAO of types A and B in rat brain when administered repeatedly. MAO activity was determined in 50% homogenates of rat brain, made up in 10 mM phosphate buffer, pH 7.4, containing 2% detergent Triton X-100. It is shown that an important role in the antidepressant effect of pirlindol is played by its property of selectively blocking deamination of neurotrans mitters such as serotonin and noradrenalin in the human brain.

Research Organization:
Institute of Biological and Medical Chemistry, Acad of Sci
OSTI ID:
6906897
Journal Information:
Bull. Exp. Biol. Med. (Engl. Transl.); (United States), Vol. 99:5
Country of Publication:
United States
Language:
English

Similar Records

The monoamine oxidase inhibition properties of selected structural analogues of methylene blue
Journal Article · Thu Jun 15 00:00:00 EDT 2017 · Toxicology and Applied Pharmacology · OSTI ID:6906897

Determination of the rate constant for neuronal and extra-neuronal monoamine oxidase
Conference · Sat Mar 01 00:00:00 EST 1986 · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) · OSTI ID:6906897

Methadone, monoamine oxidase, and depression: opioid distribution and acute effects on enzyme activity
Journal Article · Thu Sep 01 00:00:00 EDT 1983 · Biol. Psychiatry; (United States) · OSTI ID:6906897